“…Cefoxitin has been shown to penetrate cephalosporins tend to be more active against readily tissue fluid (Gillett & Wise, 1978), bile, milk (Geddes et al, 1977), ascitic fluid (Heseltine et al, 1977), and lung tissue (Perea et al, 1983). Cefoxitin has, therefore, the potential to be clinically valuable in treatment of neonatal calf diseases, such as diarrhoea, pneumonia etc., which are often caused by Gram-negative bacteria resistant to many of the commonly used antibiotics (Soback et al, 1986).…”